𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

✍ Scribed by Oettle, H.; Riess, H.; Stieler, J. M.; Heil, G.; Schwaner, I.; Seraphin, J.; Gorner, M.; Molle, M.; Greten, T. F.; Lakner, V.; Bischoff, S.; Sinn, M.; Dorken, B.; Pelzer, U.

Book ID
125521722
Publisher
American Society of Clinical Oncology
Year
2014
Tongue
English
Weight
305 KB
Volume
32
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FOLFOXIRI (folinic acid, 5-fluorouracil,
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
✍ Souglakos, J; Androulakis, N; Syrigos, K; Polyzos, A; Ziras, N; Athanasiadis, A; πŸ“‚ Article πŸ“… 2006 πŸ› Nature Publishing Group 🌐 English βš– 128 KB